Eberhardt, O <br/><br/>
Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Dec 2000 
 - 9126-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Adenoviridae--genetics<br/>Animals<br/>Apoptosis--drug effects<br/>Caspase Inhibitors<br/>Cells, Cultured<br/>Dopamine--metabolism<br/>Drug Synergism<br/>Enzyme Inhibitors--pharmacology<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Genetic Vectors--genetics<br/>Glial Cell Line-Derived Neurotrophic Factor<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Nerve Growth Factors<br/>Nerve Tissue Proteins--genetics<br/>Parkinson Disease, Secondary--chemically induced<br/>Presynaptic Terminals--drug effects<br/>Proteins--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Substantia Nigra--drug effects<br/>X-Linked Inhibitor of Apoptosis Protein